PRELIMINARY PROGRAM
Day 1 - Wednesday, 28 October | |||
9:00 | Opening of the Meeting | ||
9:05 |
| ||
Session 1: Challenges in Central and Eastern Europe | |||
9:35 |
| ||
10:00 | Transmitted and Acquired Resistance: Special Populations | ||
10:25 | |||
10:50 | ![]() Scaling-Up Integration of TB, HIV, and Viral Hepatitis Testing in Europe Speaker to be announced | ||
11:15 | Discussion | ||
11:30 | Coffee Break | ||
Industry-Sponsored Symposium | |||
12:00 | Symposium | ||
Session 2: Patient-Reported Outcomes and Studies | |||
14:00 | Introductory Lecture | ||
14:25 | Discussion | ||
Abstract-Driven Presentations | |||
14:50 | 4 slots | ||
15:50 | Coffee Break | ||
Session 3: Clinical Management of HIV: Abstract-Driven Presentations | |||
16:20 | |||
16:45 | ![]() Clinical Case Romain Palich, MD - Pitié - Salpêtrière Hospital, France | ||
17:10 | Best of Posters | ||
17:30 | Guided Poster Tour 1 | ||
Welcome Reception and Poster Viewing | |||
Day 2 - Thursday, 29 October | |||
Session 4: What's in the Pipeline? Presentations from Scientists in the Industry | |||
8:30 | ![]() Kathleen Squires, MD Global Director Scientific Affairs - ID/HIV, Merck, USA | ||
8:45 | ![]() Hanneke Schuitemaker, PhD Vice President, Head Viral Vaccine Discovery and Translational Medicine, Janssen, The Netherlands | ||
9:00 |
| ||
9:15 |
| ||
9:30 |
| ||
9:45 | Discussion | ||
10:15 | Coffee Break and Poster Viewing | ||
Guided Poster Tour 2 | |||
Industry-Sponsored Symposium | |||
11:15 | Symposium | ||
Session 5: Resistance to Long-Acting Antivirals | |||
13:15 | Resistance to Long-Acting Antivirals | ||
13:45 |
| ||
Abstract-Driven Presentations | |||
14:15 | 3 slots | ||
15:00 | Coffee Break | ||
Session 6: Management of Viral Hepatitis | |||
15:30 | Treatment of Hepatitis B for HIV Clinicians | ||
16:00 | Hepatitis C Resistance: Pro-Con Debate | ||
JM Pawlotsky, MD, PhD - University of Paris-Est, France | |||
Francesca Ceccherini - Silberstein, PhD - University of Rome “Tor Vergata”, Italy | |||
16:30 | Re-Infection and Retreatment: Challenges and Approaches | ||
Abstract-Driven Presentations | |||
17:00 | 2 slots | ||
17:30 | Guided Poster Tour 3 | ||
18:00 | End of Program Day 2 | ||
Day 3 - Friday, 30 October | |||
Session 7: PrEP and Resistance | |||
8:30 |
| ||
9:00 | Round Table Discussion: Challenges to Widespread PrEP in Europe | ||
Clinical Aspects | |||
| |||
Financial Aspects | |||
Abstract-Driven Presentations | |||
10:00 | 2 slots | ||
10:30 | Coffee Break | ||
Session 8: Vaccine Development / Immune Modulation | |||
11:00 |
| ||
11:30 |
| ||
12:00 | bnABs | ||
12:30 | ![]() Reservoirs and DNA sequencing Mathias Lichterfeld, MD, PhD - Harvard University Center for AIDS Research, USA | ||
13:00 | Closure of the Workshop and Ricardo Camacho Awards | ||